Pharmaceutical group
Neuraxpharm
A group of 15 companies with 501 medicines in 6 countries.
Group structure
15 companies in 9 countries
Loadingโฆ
Pharmaceutical group
A group of 15 companies with 501 medicines in 6 countries.
15 companies in 9 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 501
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACIDO ALENDRONICO SEMANAL QUALIGEN 70 mg COMPRIMIDOS EFG91,370 mg ยท Comprimido | Alendronic acid | Spain | Marketed | 2007 |
| ACIDO FOLICO QUALIGEN 5 MG COMPRIMIDOS5 mg ยท Comprimido | Folic acid | Spain | Marketed | 2019 |
| ACIDO IBANDRONICO QUALIGEN 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG168,79 mg ยท Comprimido recubierto con pelรญcula | Ibandronic acid | Spain | Marketed | 2011 |
| ACIRYL 150 MG CAPSULAS DURAS EFG150,0 mg ยท Cรกpsula dura | Pregabalin | Spain | Marketed | 2015 |
| ACIRYL 25 MG CAPSULAS DURAS EFG25,0 mg ยท Cรกpsula dura | Pregabalin | Spain | Marketed | 2015 |
| ACIRYL 300 MG CAPSULAS DURAS EFG300,0 mg ยท Cรกpsula dura | Pregabalin | Spain | Marketed | 2015 |
| ACIRYL 75 MG CAPSULAS DURAS EFG75,0 mg ยท Cรกpsula dura | Pregabalin | Spain | Marketed | 2015 |
| ADOLDEX 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA36,90 mg ยท Comprimido recubierto con pelรญcula | Dexketoprofen | Spain | Marketed | 2013 |
| AGOMELATINA QUALIGEN 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGIgual a 44.739 mg mg ยท Comprimido recubierto con pelรญcula | Agomelatina acido citrico | Spain | Marketed | 2018 |
| Agomelatine neuraxpharm 25 mg filmomhulde tablettenFilmomhulde tablet | Agomelatine | Netherlands | Authorised | 2018 |
| ALERTEC100 mg ยท Tablet | Modafinil | Canada | Marketed | 1999 |
| ANSIUM CAPSULAS DURAS5,00 mg + 50,00 mg ยท Cรกpsula dura | Diazepam, Sulpiride | Spain | Marketed | 1975 |
| ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG10 mg ยท Comprimido recubierto con pelรญcula | Olanzapine | Spain | Marketed | 2007 |
| ARENBIL 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG2,5 mg ยท Comprimido recubierto con pelรญcula | Olanzapine | Spain | Marketed | 2007 |
| ARENBIL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5,0 mg ยท Comprimido recubierto con pelรญcula | Olanzapine | Spain | Marketed | 2007 |
| ARENBIL 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG7,5 mg ยท Comprimido recubierto con pelรญcula | Olanzapine | Spain | Marketed | 2007 |
| ARENBIL FLAS 10 mg COMPRIMIDOS BUCODISPERSABLES EFG10,00 mg ยท Comprimido bucodispersable | Olanzapine | Spain | Marketed | 2011 |
| ARENBIL FLAS 15 mg COMPRIMIDOS BUCODISPERSABLES EFG15,00 mg ยท Comprimido bucodispersable | Olanzapine | Spain | Marketed | 2011 |
| ARENBIL FLAS 20 mg COMPRIMIDOS BUCODISPERSABLES EFG20,00 mg ยท Comprimido bucodispersable | Olanzapine | Spain | Marketed | 2011 |
| ARENBIL FLAS 5 mg COMPRIMIDOS BUCODISPERSABLES EFG5,00 mg ยท Comprimido bucodispersable | Olanzapine | Spain | Marketed | 2011 |
| ARIPIPRAZOL QUALIGEN 10 MG COMPRIMIDOS EFG10 mg ยท Comprimido | Aripiprazole | Spain | Marketed | 2015 |
| ARIPIPRAZOL QUALIGEN 15 MG COMPRIMIDOS EFG15 mg ยท Comprimido | Aripiprazole | Spain | Marketed | 2015 |
| ARIPIPRAZOL QUALIGEN 20 MG COMPRIMIDOS20 mg ยท Comprimido | Aripiprazole | Spain | Marketed | 2018 |
| ARIPIPRAZOL QUALIGEN 5 MG COMPRIMIDOS EFG5 mg ยท Comprimido | Aripiprazole | Spain | Marketed | 2015 |
| ARIZOL 10 MG COMPRIMIDOS EFG10 mg ยท Comprimido | Aripiprazole | Spain | Marketed | 2015 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 410 | 337 | 73 | CompaniesAll medicines |
| Netherlands | 72 | 72 | 0 | CompaniesAll medicines |
| European Union (EMA) | 9 | 8 | 1 | CompaniesAll medicines |
| Canada | 6 | 6 | 0 | CompaniesAll medicines |
| Croatia | 3 | 3 | 0 | CompaniesAll medicines |
| Brazil | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, France, Germany, Italy, Malaysia, Singapore, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Agรชncia Nacional de Vigilรขncia Sanitรกria (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Bundesinstitut fรผr Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Licence: commercial redistribution permission not established
Origen de los datos:AEMPS,Registro pรบblico LABOFAR;original URL,source update date when present and separate retrieval date;Prognia normalization;no endorsement.
Licence: AEMPS public factual register statutory reuse;custom source/date conditions
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods JanuaryโSeptember 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65fc6f1ba855cc196a8ba/New_Manufacturing_and_Wholesale_Dealer_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:18.644817+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA published licence history
GLEIF; exact source URL and retrieval date; no endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Register prรกvnickรฝch osรดb, podnikateฤพov a orgรกnov verejnej moci; public API licence names ล tatistickรฝ รบrad Slovenskej republiky; administration transferred to Ministerstvo vnรบtra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence: Creative Commons Attribution
Slovak Ministry of Finance, Register รบฤtovnรฝch zรกvierok (RรZ) Open API; exact IฤO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence: CC0
Report an error or request removalCorrections from the company itself are welcome.
Keep Neuraxpharmโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.